Last reviewed · How we verify
Sodium < 1mEq/kg/day
Sodium < 1mEq/kg/day is a Small molecule drug developed by Hospital del Niño "Dr. Federico Gomez Santos". It is currently FDA-approved for Fluid overload management in pediatric patients, Heart failure in children, Chronic kidney disease with sodium retention.
Sodium restriction at <1mEq/kg/day reduces total body sodium content to manage fluid balance and electrolyte homeostasis.
Sodium restriction at <1mEq/kg/day reduces total body sodium content to manage fluid balance and electrolyte homeostasis. Used for Fluid overload management in pediatric patients, Heart failure in children, Chronic kidney disease with sodium retention.
At a glance
| Generic name | Sodium < 1mEq/kg/day |
|---|---|
| Sponsor | Hospital del Niño "Dr. Federico Gomez Santos" |
| Modality | Small molecule |
| Therapeutic area | Cardiology, Nephrology, Pediatrics |
| Phase | FDA-approved |
Mechanism of action
This is a dietary sodium restriction protocol rather than a pharmacological drug. It limits daily sodium intake to less than 1 milliequivalent per kilogram of body weight, which reduces extracellular fluid volume and helps manage conditions characterized by sodium and fluid retention. This approach is commonly used in pediatric patients with conditions such as heart failure, renal disease, or hypertension.
Approved indications
- Fluid overload management in pediatric patients
- Heart failure in children
- Chronic kidney disease with sodium retention
- Hypertension management in pediatric populations
Common side effects
- Hyponatremia
- Nutritional deficiency if overly restrictive
- Palatability issues and dietary non-adherence
Key clinical trials
- Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD (PHASE2)
- Early Sodium Intake in Preterm Newborns (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sodium < 1mEq/kg/day CI brief — competitive landscape report
- Sodium < 1mEq/kg/day updates RSS · CI watch RSS
- Hospital del Niño "Dr. Federico Gomez Santos" portfolio CI
Frequently asked questions about Sodium < 1mEq/kg/day
What is Sodium < 1mEq/kg/day?
How does Sodium < 1mEq/kg/day work?
What is Sodium < 1mEq/kg/day used for?
Who makes Sodium < 1mEq/kg/day?
What development phase is Sodium < 1mEq/kg/day in?
What are the side effects of Sodium < 1mEq/kg/day?
Related
- Manufacturer: Hospital del Niño "Dr. Federico Gomez Santos" — full pipeline
- Therapeutic area: All drugs in Cardiology, Nephrology, Pediatrics
- Indication: Drugs for Fluid overload management in pediatric patients
- Indication: Drugs for Heart failure in children
- Indication: Drugs for Chronic kidney disease with sodium retention
- Compare: Sodium < 1mEq/kg/day vs similar drugs
- Pricing: Sodium < 1mEq/kg/day cost, discount & access